KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacira BioSciences (PCRX) Restructuring Costs: 2021-2024

Historic Restructuring Costs for Pacira BioSciences (PCRX) over the last 4 years, with Dec 2024 value amounting to $7.7 million.

  • Pacira BioSciences' Restructuring Costs rose 484.54% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.4 million, marking a year-over-year increase of 1207.02%. This contributed to the annual value of $7.7 million for FY2024, which is 2288.07% up from last year.
  • As of FY2024, Pacira BioSciences' Restructuring Costs stood at $7.7 million, which was up 2,288.07% from -$352,000 recorded in FY2023.
  • Pacira BioSciences' 5-year Restructuring Costs high stood at $10.9 million for FY2022, and its period low was -$42.9 million during FY2021.
  • In the last 3 years, Pacira BioSciences' Restructuring Costs had a median value of $7.7 million in 2024 and averaged $6.1 million.
  • Per our database at Business Quant, Pacira BioSciences' Restructuring Costs plummeted by 103.23% in 2023 and then soared by 2,288.07% in 2024.
  • Over the past 4 years, Pacira BioSciences' Restructuring Costs (Yearly) stood at -$42.9 million in 2021, then surged by 125.41% to $10.9 million in 2022, then plummeted by 103.23% to -$352,000 in 2023, then soared by 2,288.07% to $7.7 million in 2024.